Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Neuron-generating stem cells hold promise for multiple sclerosis

A trial aimed at evaluating safety offers hints that stem cells preserve grey matter in people with the neurodegenerative disease.
Coloured axial MRI scan of the brain of a patient with multiple sclerosis

The brain of a person with multiple sclerosis, caused by loss of nerve cells and their protective sheaths. Credit: Zephyr/Science Photo Library

Stem cells injected into the spinal fluid of people with multiple sclerosis show promise as a treatment for the disease, a small trial suggests1.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 613, 416 (2023)

doi: https://doi.org/10.1038/d41586-023-00037-w

References

  1. Genchi, A. et al. Nature Med. https://doi.org/10.1038/s41591-022-02097-3 (2023).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links